Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / exhibit-c-form-site-joinder.docx
exhibit-c-form-site-joinder.docx
Parties
Penterra Pharmaceuticals Corp
Clinical Contracts Penterra Pharmaceuticals Corp
Dates
June 28, 2023
April 1, 2023
March 31, 2024
January 21, 2019
Amounts
$52,000
$13,000
$75,000
$37,500
$40,000
$1,500,000
$500,000
$15,000,000
$5,000,000
$20,000,000
Obligations
1 — Definitions All capitalized terms used but not otherwise defined in this Site Agreement shall have the meanings ascribed to them in the MCTA
In addition to the definitions set forth in the MCTA, the following terms shall have the meanings set forth below when used in this Site Agreement: (a) "IRB" means the Institutional Review Board or Ethics Committee identified in Site-Specific Schedule C attached hereto, which shall serve as the IRB of record for the conduct of the Protocol at the Site
This Site Agreement constitutes a joinder to the MCTA, and the Site shall be deemed a party to the MCTA from and after the Site Agreement Effective Date for all purposes related to the conduct of the Protocol at the Site
If the Site is not currently listed on Schedule 1, the Network shall update Schedule 1 to include the Site concurrently with the execution of this Site Agreement
The Site shall not destroy, discard, or transfer any study records without the prior written consent of Sponsor
The Site shall make every reasonable effort to accommodate monitoring visits conducted by the CRO on a schedule mutually agreed upon by the Site and the CRO, and shall make the PI and key site personnel available during such visits